Target cells in vaginal HIV transmission

Microbes and Infection

Volumn 5, Issue 1, 2003, Pages 59-67

  Miller, Christopher J ^a   Shattock, Robin J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Epithelium; Inflammation; Langerhans cells; SIV

Indexed keywords

ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL FUNCTION; CELL MIGRATION; CELLULAR DISTRIBUTION; DENDRITIC CELL; DISEASE MODEL; EPIDEMIC; EPITHELIUM; EXPLANT; FEMALE GENITAL SYSTEM; GENITAL TRACT INFECTION; HOST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INFECTION CONTROL; INFECTION RISK; INFECTION SENSITIVITY; LAMINA PROPRIA; LANGERHANS CELL; LYMPHOCYTE; LYMPHOID TISSUE; MACROPHAGE; MENARCHE; MUCOSAL IMMUNITY; NONHUMAN; ORAL CONTRACEPTION; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; TARGET CELL; TISSUE; VAGINA; VAGINA ATROPHY; VAGINA EPITHELIUM; VAGINITIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; EPITHELIUM; FEMALE; HIV; HIV INFECTIONS; HUMANS; IMMUNOLOGIC FACTORS; MACACA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA;

SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0037276929     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)00056-4     Document Type: Review

References (83)

1. Wortley P.M., Hammett T.A., Fleming P.L. Donor insemination and human immunodeficiency virus transmission. Obstet. Gynecol. 91:1998;515-518.
2. Stewart G.J., Tyler J.P.P., Cunningham A.L., Barr G.L., Driscoll G.L., Gold J., Lamont B.J. Transmission of human T-cell lymphotropic virus (HTLV-III) by artificial insemination by donor. Lancet. 2:1985;581-584.
3. Miller C.J., McGhee J.R., Gardner M.B. Mucosal immunity, HIV transmission and AIDS. Lab. Invest. 68:1993;129-145.
4. Kell P.D., Barton S.E., Edmonds D.K., Boag F.C. HIV infection in a patient with Meyer-Rokitansky-Kuster-Hauser Syndrome. J. R. Soc. M. 85:1992;706-707.
5. Miller C.J., Alexander N.J., Sutjipto S., Lackner A.A., Hendrickx A.G., Gettie A., Lowenstine L.J., Jennings M., Marx P.A. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J. Virol. 63:1989;4277-4284.
6. Miller C.J., Marthas M., Torten J., Alexander N.J., Moore J.P., Doncel G.F., Hendrickx A.G. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J. Virol. 68:1994;6391-6400.
7. Miller C.J., Marthas M., Greenier J., Lu D., Dailey P.J., Lu Y. In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques. J. Virol. 72:1998;3248-3258.
8. Miller C.J., Alexander N.J., Vogel P., Anderson J., Marx P.A. Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J. Med. Primatol. 21:1992;64-68.
9. Greenier J.L., Miller C.J., Lu D., Dailey P.J., Lu F.X., Kunstman K.J., Wolinsky S.M., Marthas M.L. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques. J. Virol. 75:2001;3753-3765.
10. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
11. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:1996;667-673.
12. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1996;1955-1958.
13. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 273:1996;1856-1862.
14. Liu R., Paxton W., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald M.E., Stuhlmann H., Koup R.A., Landau N.R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
15. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., Cornelissen I.L., Nottet H.S., Kewal Ramani V.N., Littman D.R., Figdor C.G., van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 100:2000;587-597.
16. Pohlmann S., Baribaud F., Doms R.W. DC-SIGN and DC-SIGNR: helping hands for HIV. Trends Immunol. 22:2001;643-646.
17. Turville S.G., Arthos J., Donald K.M., Lynch G., Naif H., Clark G., Hart D., Cunningham A.L. HIV gp120 receptors on human dendritic cells. Blood. 98:2001;2482-2488.
18. Wu L., Bashirova A.A., Martin T.D., Villamide L., Mehlhop E., Chertov A.O., Unutmaz D., Pope M., Carrington M., Kewal Ramani V.N. Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN. Proc. Natl. Acad. Sci. USA. 99:2002;1568-1573.
19. Robboy S.J., Prade M., Cunha G. Sternberg S.S. Histology for Pathologists. 1992;881-892 Raven Press, North Holland, New York.
20. Shattock R.J., Griffin G.E., Gorodeski G.I. In vitro models of mucosal HIV transmission. Nat. M. 6:2000;607-608.
21. King B.F. The permeability of nonhuman primate vaginal epithelium: a freeze-fracture and tracer-perfusion study. J. Ultrastruct. Res. 83:1983;99-110.
22. Moriyama A., Shimoya K., Ogata I., Kimura T., Nakamura T., Wada H., Ohashi K., Azuma C., Saji F., Murata Y. Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. Mol. Hum. Reprod. 5:1999;656-661.
23. Agace W.W., Amara A., Roberts A.I., Pablos J.L., Thelen S., Uguccioni M., Li X.Y., Marsal J., Arenzana-Seisdedos F., Delaunay T., Ebert E.C., Moser B., Parker C.M. Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Curr. Biol. 10:2000;325-328.
24. Miller C.J., McChesney M., Moore P.F. Langerhans cells, macrophages and lymphocyte subsets in the cervix and vagina of rhesus macaques. Lab. Invest. 67:1992;628-634.
25. Ma Z., Lu F.X., Torten M., Miller C.J. The number and distribution of immune cells in the cervicovaginal mucosa remain constant throughout the menstrual cycle of rhesus macaques. Clin. Immunol. 100:2001;240-249.
26. Fawcett D.W. Bloom and Fawcett's Textbook of Histology. 1986;Saunders, Philadelphia.
27. Edwards J.N.T., Morris H.B. Langerhans cells and lymphocyte subsets in the female genital tract. Br. J. Obstet. Gynecol. 92:1985;974-982.
28. Hladik F., Lentz G., Delpit E., McElroy A., McElrath M.J. Coexpression of CCR5 and IL-2 in human genital but not blood T cells: implications for the ontogeny of the CCR5+ Th1 phenotype. J. Immunol. 163:1999;2306-2313.
29. Patton D.L., Thwin S.S., Meier A., Hooton T.M., Stapleton A.E., Eschenbach D.A. Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am. J. Obstet. Gynecol. 183:2000;967-973.
30. Musey L., Hu Y., Eckert L., Christensen M., Karchmer T., McElrath M.J. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J. Exp. M. 185:1997;293-303.
31. Lohman B.L., Miller C.J., McChesney M.B. Antiviral cytotoxic T lymphocytes in the vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J. Immunol. 155:1995;5855-5860.
32. Morris H.H.B., Gatter K.C., Stein H., Mason D.Y. Langerhans cells in human cervical epithelium: an immunohistologic study. Br. J. Obstet. Gynecol. 90:1983;400-411.
33. Bjercke S., Scott H., Braathen L.R., Thorsby E. HLA-DR-expressing Langerhans-like cells in vaginal and cervical epithelium. Acta Obstet. Gynecol. Scand. 62:1983;585-589.
34. Palacio J., Souberbielle B.E., Shattock R.J., Robinson G., Manyonda I., Griffin G.E. In vitro HIV1 infection of human cervical tissue. Res. Virol. 145:1994;155-161.
35. Lee B., Sharron M., Montaner L.J., Weissman D., Doms R.W. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc. Natl. Acad. Sci. USA. 96:1999;5215-5220.
36. Zoeteweij J.P., Blauvelt A. HIV-dendritic cell interactions promote efficient viral infection of T cells. J. Biomed. Sci. 5:1998;253-259.
37. Zaitseva M., Blauvelt A., Lee S., Lapham C.K., Klaus-Kovtun V., Mostowski H., Manischewitz J., Golding H. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat. M. 1997;1369-1375.
38. Weissman D., Rubbert A., Combadiere C., Murphy P.M., Fauci A.S. Dendritic cells express and use multiple HIV coreceptors. Adv. Exp. Med. Biol. 417:1997;401-406.
39. Rubbert A., Combadiere C., Ostrowski M., Arthos J., Dybul M., Machado E., Cohn M.A., Hoxie J.A., Murphy P.M., Fauci A.S., Weissman D. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. J. Immunol. 160:1998;3933-3941.
40. Zhang L., He T., Talal A., Wang G., Frankel S.S., Ho D.D. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J. Virol. 72:1998;5035-5045.
41. Rottman J.B., Ganley K.P., Williams K., Wu L., Mackay C.R., Ringler D.J. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am. J. Pathol. 151:1997;1341-1351.
42. Parr M.B., Kepple L., Parr E.L. Antigen recognition in the female reproductive tract: II. Endocytosis of horseradish peroxidase by Langerhans cells in murine vaginal epithelium. Biol. Reprod. 45:1991;261-265.
43. Romani N., Ratzinger G., Pfaller K., Salvenmoser W., Stossel H., Koch F., Stoitzner P. Migration of dendritic cells into lymphatics - the Langerhans cell example: routes, regulation, and relevance. Int. Rev. Cytol. 207:2001;237-270.
44. Kawamura T., Cohen S.S., Borris D.L., Aquilino E.A., Glushakova S., Margolis L.B., Orenstein J.M., Offord R.E., Neurath A.R., Blauvelt A. Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J. Exp. M. 192:2000;1491-1500.
45. Tchou I., Misery L., Sabido O., Dezutter-Dambuyant C., Bourlet T., Moja P., Hamzeh H., Peguet-Navarro J., Schmitt D., Genin C., Functional H.I.V. CXCR4 coreceptor on human epithelial Langerhans cells and infection by HIV strain X4. J. Leukoc. Biol. 70:2001;313-321.
46. Chou L.L., Epstein J., Cassol S.A., West D.M., He W., Firth J.D. Oral mucosal Langerhans' cells as target, effector and vector in HIV infection. J. Oral. Pathol. M. 29:2000;394-402.
47. Bhoopat L., Eiangleng L., Rugpao S., Frankel S.S., Weissman D., Lekawanvijit S., Petchjom S., Thorner P., Bhoopat T. In vivo identification of Langerhans and related dendritic cells infected with HIV-1 subtype E in vaginal mucosa of asymptomatic patients. Mod. Pathol. 14:2001;1263-1269.
48. Hu J., Pope M., Brown C., O'Doherty U., Miller C.J. Immunophenotypic characterization of SIV-infected dendritic cells in the cervix, vagina and draining lymph nodes of rhesus macaques. Lab. Invest. 78:1998;435-451.
49. Hu J., Gardner M.B., Miller C.J. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 74:2000;6087-6095.
50. Kunanusont C., Foy H.M., Kreiss J.K., Rerks-Ngarm S., Phanuphak P., Raktham S., Pau C.P., Young N.L. HIV-1 subtypes and male-to-female transmission in Thailand. Lancet. 345:1995;1078-1083.
51. Strathdee S.A., Hogg R.S., O'Shaughnessy M.V., Montaner J.S., Schechter M.T. A decade of research on the natural history of HIV infection: Part 2. Cofactors. Clin. Invest. M. 19:1996;121-130.
52. Cohen C.R., Duerr A., Pruithithada N., Rugpao S., Hillier S., Garcia P., Nelson K. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS. 9:1995;1093-1097.
53. Sewankambo N., Gray R.H., Wawer M.J., Paxton L., McNaim D., Wabwire-Mangen F., Serwadda D., Li C., Kiwanuka N., Hillier S.L., Rabe L., Gaydos C.A., Quinn T.C., Konde-Lule J. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet. 350:1997;546-550.
54. Patterson S., Knight S.C. Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. J. Gen. Virol. 68:1987;1177-1181.
55. Blauvelt A., Asada H., Saville M.W., Klaus-Kovuton V., Altman D.J., Yarchoan R., Katz S.I. Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated by separate pathways. J. Clin. Invest. 100:1997;2043-2053.
56. Macdonald T.H.J., Shattock R.J., Madsen C., Chain B.M., Katz D.R. Regulation of primary HIV-1 isolates in dendritic cells. Clin. Exp. Immunol. 127:2002;66-71.
57. Langhoff E.F., Terwilliger E.F., Bos H.J., Kalland K.H., Pozansky M.C., Bacon O.M.L., Haseltine W.A. Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. Proc. Natl. Acad. Sci. USA. 88:1991;7998-8002.
58. Phillips D.M., Bourinbaiar A.S. Mechanism of HIV spread from lymphocytes to epithelia. Virology. 186:1992;261-273.
59. Hocini H., Bomsel M. Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. J. Infect. Dis. 179:(Suppl. 3):1999;S448-S453.
60. Greenhead P., Hayes P., Watts P.S., Laing K.G., Griffin G.E., Shattock R.J. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J. Virol. 12:2000;5577-5586.
61. Dezzutti C.S., Guenthner P.C., Cummins J.E. Jr, Cabrera T., Marshall J.H., Dillberger A., Lal R.B. Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J. Infect. Dis. 183:2001;1204-1213.
62. Reece J.C., Handley A.J., Anstee E.J., Morrison W.A., Crowe S.M., Cameron P.U. HIV-1 selection by epidermal dendritic cells during transmission across human skin. J. Exp. M. 187:1998;1623-1631.
63. Collins K.B., Patterson B.K., Naus G.J., Landers D.V., Gupta P. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat. M. 6:2000;475-479.
64. Zacharopoulos V.R., Perotti M.E., Phillips D.M. A role for cell migration in the sexual transmission of HIV-1? Curr. Biol. 7:1997;534-537.
65. Ibata B., Parr E.L., King N.J., Parr M.B. Migration of foreign lymphocytes from the mouse vagina into the cervicovaginal mucosa and to the iliac lymph nodes. Biol. Reprod. 56:1997;537-543.
66. Smith S.M., Baskin G.B., Marx P.A. Estrogen protects against vaginal transmission of simian immunodeficiency virus. J. Infect. Dis. 182:2000;708-715.
67. Marx P.A., Spira A.I., Gettie A., Dailey P.J., Veazey R.S., Lackner A.A., Mahoney C.J., Miller C.J., Claypool L.E., Ho D.D., Alexander N.J. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. M. 2:1996;1084-1089.
68. Mauck C.K., Callahan M.M., Baker J., Arbogast K., Veazey R., Stock R., Pan Z., Morrison C.S., Chen-Mok M., Archer D.F., Gabelnick H.L. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy. Contraception. 60:1999;15-24.
69. Lu F.X., Abel K., Ma Z., Rourke T., Lu D., Torten J., McChesney M., Miller C.J. The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones. Clin. Exp. Immunol. 128:2002;10-20.
70. Sodora D.L., Gettie A., Miller C.J., Marx P.A. Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res. Hum. Retroviruses. 14:(Suppl. 1):1998;S119-S123.
71. Harouse J., Gettie A., Eshetu T., Fuller R., Blanchard J., Cheng-Mayer C. Co-transmission and growth of CCR5 and CxCR4 specific SHIVs after intravaginal or intravenous exposure. 19th Annual Symposium on Nonhuman Primate Models for AIDS:7-10 November 2001; (Abstract #2).
72. Spira A.I., Marx P.A., Patterson B.K., Mahoney J., Koup R.A., Wolinsky S.M., Ho D.D. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. M. 183:1996;215-225.
73. Masurier C., Salomon B., Guettari N., Pioche C., Lachapelle F., Guigon M., Klatzmann D. Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice. J. Virol. 72:1998;7822-7829.
74. Nuovo G.J., Forde A., MacConnell P., Fahrenwald R. In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues. Am. J. Pathol. 143:1993;40-48.
75. Pomerantz R.J., de la Monte S.M., Donegan C.E., Rota T.R., Vogt M.W., Craven D.E., Hirsch M.S. Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann. Int. M. 108:1988;321-327.
76. Miller C.J., Vogel P., Alexander N.J., Sutjipto S., Hendrickx A.G., Marx P.A. Localization of SIV in the genital tract of chronically infected female rhesus macaques. Am. J. Pathol. 141:1992;655-660.
77. Zambruno G., Mori L., Marconi A., Mongiardo N., De Rienzo B., Bertazzoni U., Giannetti A. Detection of HIV-1 in epidermal Langerhans cells of HIV-infected patients using polymerase chain reaction. J. Invest. Dermatol. 96:1991;979-982.
78. Tschachler E., Groh V., Popvic M., Mann D.L., Konrad K., Safai B., Eron L., diMarzo-Veronese F., Wolff K., Stingl G. Epidermal Langerhans cells: a target for HTLV-III/LAV infection. J. Invest. Dermatol. 88:1987;233-237.
79. Novell M.K., Benrudi G.I., Thompson R.J. Investigation of microtrauma after sexual intercourse. J. Reprod. M. 29:1984;269-271.
80. Kinter A.L., Ostrowski M., Goletti D., Oliva A., Weissman D., Gantt K., Hardy E., Jackson R., Ehler L., Fauci A.S. HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. Proc. Natl. Acad. Sci. USA. 93:1996;14076-14081.
81. Leng Q., Borkow G., Weisman Z., Stein M., Kalinkovich A., Bentwich Z. Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection. J. Acquired Immune Defic. Syndr. 27:2001;389-397.
82. Fais S., Lapenta C., Santini S.M., Spada M., Parlato S., Logozzi M., Rizza P., Belardelli F. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection. J. Virol. 73:1999;6453-6459.
83. Grosskurth H., Mosha F., Todd J., Mwijarubi E., Klokke A., Senkoro K., Mayaud P., Changalucha J., Nicoll A., ka-Gina G., et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995;530-536.